Adiso
Adiso is a biotech company in United States, founded in 2022. It has raised $60.0M across 1 round, most recently a $60.0M Seed in March 2022.
Adiso Therapeutics — Advancing Novel Therapies For Inflammatory Diseases
- Employees
- 1–10
- Founded
- 2022
- Business Model
- B2B
- Website
- adisotx.com
- Total Funding
- $60.0M
- Last Round
- $60.0M SeedMar 2022
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.
About
Adiso creates medicines to treat inflammatory diseases and advances multi-modal agents with novel mechanisms of action. Its pipeline follows a precision therapeutic approach to developing treatments for inflammatory disease. This development strategy combines multi-modal agents and novel mechanisms of action within a precision-focused therapeutic pipeline.
Summary
It lists 1–10 employees. It has raised $60.0M in total across 1 round, most recently a $60.0M Seed round in Mar 2022. Investors include Morningside Group.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Mar 2022
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/adiso"><img src="https://indexed.vc/api/badge/company/adiso" alt="Adiso on Indexed.vc" width="260" height="76" /></a>